Compare FLL & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | DRIO |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6M | 18.5M |
| IPO Year | 2014 | 2013 |
| Metric | FLL | DRIO |
|---|---|---|
| Price | $0.38 | $1.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $1.56 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 521.9K | 73.3K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.45 | ★ 1559.02 |
| EPS | N/A | ★ 2.46 |
| Revenue | ★ $302,376,000.00 | $7,394,000.00 |
| Revenue This Year | $3.53 | N/A |
| Revenue Next Year | $4.48 | $32.43 |
| P/E Ratio | ★ N/A | $0.59 |
| Revenue Growth | 3.53 | ★ 43.02 |
| 52 Week Low | $0.34 | $1.09 |
| 52 Week High | $3.37 | $14.49 |
| Indicator | FLL | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 22.68 | 24.17 |
| Support Level | N/A | N/A |
| Resistance Level | $1.19 | $8.01 |
| Average True Range (ATR) | 0.08 | 0.47 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 11.02 | 11.00 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.